ADHD Drug Shortages Draw Attention In Congress, Court
Executive Summary
Lawmakers seek information from Shire, Novartis and the Drug Enforcement Administration as to the reason behind short supplies of some attention deficit/hyperactivity disorder drugs. A legal dispute over supply of an Adderall XR authorized generic is slated for trial in April.
You may also be interested in...
Sandoz Weighs In On US Adderall Shortages Amid Supply Disruption
A spike in demand for Adderall and its generic versions has left patients scrambling to have their prescriptions filled, making headline news in the US. Leading generics manufacturer Sandoz told Generics Bulletin its current experience amid the supply squeeze.
“Comprehensive” Drug Shortage Mitigation Bill Under Development In House
Like the Senate proposal, it could include reimbursement rate adjustments in addition to requiring early notification of shortages by manufacturers, but questions remain about ensuring there are no unintended consequences.
Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing
Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.